EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)

Rena C Patel iD, Patrick Oyaro iD, Katherine K Thomas, Garoma Wakjira Basha, James Wagude, Irene Mukui, Evelyn Brown, Shukri A Hassan, Eunice Kinywa, Fredrick Oluoch, Francesca Odhiambo, Boaz Oyaro und 6 weitere

Journal of the International AIDS Society · 2023

DOI: 10.1002/jia2.26182 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the International AIDS Society, 2023. Verfasst von Rena C Patel und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCATS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lack of viral suppression (VS) among pregnant and breastfeeding women living with HIV poses challenges for maternal and infant health, and viral load (VL) monitoring via centralized laboratory systems faces many barriers. We aimed to determine the impact of point‐of‐care (POC) VL and targeted drug resistance mutation (DRM) testing in improving VS among pregnant and postpartum women on antiretroviral therapy.

Methods

We conducted a pre/post‐intervention prospective cohort study among 820 pregnant women accessing HIV care at five public‐sector facilities in western Kenya from 2019 to 2022. The pre‐intervention or “control” group consisted of standard‐of‐care (SOC) centralized VL testing every 6 months and the post‐intervention or “intervention” group consisted of a combined strategy of POC VL every 3 months, targeted DRM testing, and clinical management support. The primary outcome was VS (VL ≤1000 copies/ml) at 6 months postpartum; secondary outcomes included uptake and turnaround times for VL testing and sustained VS.

Results

At 6 months postpartum, 321/328 (98%) of participants in the intervention group and 339/347 (98%) in the control group achieved VS (aRR 1.00, 95% confidence interval [CI] 0.98, 1.02). When assessing VS using a threshold of 1000 copies/ml) who underwent successful DRM testing in the intervention group, all (46/46, 100%) had some DRMs and 20 (43%) had major DRMs (of which 80% were nucleos(t)ide reverse transcriptase inhibitor mutations). POC VL testing uptake was high (>89%) throughout pregnancy, delivery, and postpartum periods, with a median turnaround time of 1 day (IQR 1, 4) for POC VL in the intervention group and 7 days (IQR 5, 9) for SOC VL in the control group. Sustained VS throughout follow‐up was similar between groups with either POC or SOC VL testing (90−91% for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsInfantHumansPregnancyFemaleKenyaProspective StudiesPoint-of-Care SystemsViral LoadPostpartum Period

Stichwörter der Autor:innen

HIVantiretroviral therapy (ART)drug resistance mutations (DRMs)point-of-care (POC) testingpregnant and postpartum womenviral load

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Department of Medicine, University of Alabama, Birmingham, UK.
  • Health Innovations Kenya (HIK), Kisumu, Kenya.
  • Department of Health, Siaya County, Kenya.
  • Drugs for Neglected Diseases Initiative (DNDI), Nairobi, Kenya.

ORCID-Profile: Rena C Patel, Patrick Oyaro

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Patel, R. C., Oyaro, P., Thomas, K. K., Basha, G. W., Wagude, J., Mukui, I., Brown, E., Hassan, S. A., Kinywa, E., Oluoch, F., Odhiambo, F., Oyaro, B., Kingwara, L., Karauki, E., Yongo, N., Otieno, L., John-Stewart, G. C., & Abuogi, L. L. (2023). Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas). Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26182

Vancouver

Patel RC, Oyaro P, Thomas KK, Basha GW, Wagude J, Mukui I, et al. Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas). Journal of the International AIDS Society. 2023. doi:10.1002/jia2.26182

BibTeX
@article{Patel2023,
  author = {Patel, Rena C and Oyaro, Patrick and Thomas, Katherine K and Basha, Garoma Wakjira and Wagude, James and Mukui, Irene and Brown, Evelyn and Hassan, Shukri A and Kinywa, Eunice and Oluoch, Fredrick and Odhiambo, Francesca and Oyaro, Boaz and Kingwara, Leonard and Karauki, Enericah and Yongo, Nashon and Otieno, Lindah and John-Stewart, Grace C and Abuogi, Lisa L},
  title = {Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)},
  journal = {Journal of the International AIDS Society},
  year = {2023},
  doi = {10.1002/jia2.26182}
}
Kostenlos starten →